What is the difference between Inflectra and Remicade?

Inflectra (infliximab-dyyb) is a biosimilar to Janssen’s Remicade (infliximab)

Inflectra (infliximab-dyyb) and Remicade (infliximab) belong to the class of drugs called tumor necrosis factor (TNF) alfa inhibitors.

A biosimilar must have no clinically meaningful safety or effectiveness differences from the reference product, but it is not considered identical like a generic product.

What Are Biosimilars? Top Facts You May Not Know

Inflectra can be prescribed for the same uses as Remicade, including rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis.

For additional information, see Comparing Inflectra vs Remicade